ArticleCureus2025
Type 3 Sturge-Weber Syndrome Presenting With Concurrent Epilepsy and Migraine.
Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Sturge-Weber syndrome is a rare congenital disorder with vascular malformations affecting the brain, skin, and eyes. Type 3 Sturge-Weber syndrome, the rarest form, presents with isolated leptomeningeal angiomas, often causing diagnostic delays. This report highlights an unusual presentation where both recurrent focal seizures and migraine-like headaches were prominent, long-standing features. A 30-year-old man presented with two focal seizures affecting the right side of his body, preceded by aura and followed by postictal confusion, right-sided weakness, and migraine-like headache with photophobia and vomiting. He had experienced focal seizures since childhood, with worsening postictal symptoms and progressive headaches over time. Examination revealed disorientation and right-sided weakness, while laboratory findings showed hyperglycemia, consistent with undiagnosed diabetes. Neuroimaging revealed leptomeningeal enhancement, tram-track calcifications, and cortical atrophy in the left parietal region, confirming type 3 Sturge-Weber syndrome. Notably, the patient had newly diagnosed diabetes, suggesting a possible metabolic link to Sturge-Weber syndrome. Management included antiepileptic therapy and glycemic control, leading to clinical improvement. The heterogeneous neurological presentation of type 3 Sturge-Weber syndrome often delays recognition. Early neuroimaging and a high index of suspicion are essential for timely diagnosis, particularly in the absence of cutaneous features.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.